The ELG Analysis of Glucose a Correlational to Blood Glucose Assay

A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 100 participants.

Also called NCT05055804

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose supportive care
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
XP Technology, LLC (from the registry)
Registry
  • NCT NCT05055804
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Enrolling by invitation (from the registry)

Technical summary

Registry record NCT05055804. Allocation not applicable; no masking; primary purpose supportive care. Start 2021-08-11 (actual); primary completion 2025-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The ELG Analysis of Glucose a Correlational to Blood Glucose Assay
Condition
Diabetes Mellitus, Type 1
Condition
Diabetes Mellitus, Type 2
Intervention (Device)
ELG
Lead sponsor
XP Technology, LLC (class: other)

Record details

Record id
cardio:ct-nct05055804
Content hash
e21e3626f0e95fcdae63b876f20112255206f587f5fb0f7c6858dc7325ebcf10